Maintenance Therapy With Selinexor in Patients With Endometrial Cancer

Posted: 08/02/2023 | By: Chase Doyle

Results of the phase III ENGOT-EN5/GOG-3055/SIENDO study, which evaluated the efficacy of maintenance selinexor in patients with advanced or recurrent endometrial cancer, were presented by Slomovitz et al during the ASCO Plenary Series: July 2023 Session.

Question 1 of 5

Through what mechanism does selinexor induce cell death in endometrial cancer?

Choose 1